Profusa and Partners Announce Initiation of Study to Measure Early Signs of Influenza Through Biosensor Technology
DARPA-Backed Study Leverages Profusa’s Lumee® Oxygen Platform as Part of a Larger Effort to Speed Detection and Predict Disease Outbreaks EMERYVILLE, Calif., March 3, 2020 – Profusa, a digital health company that is pioneering the next generation of personalized medicine, today announced the initiation of a study that will use the Company’s minimally invasive injectable […]
Research Presented at LINC Suggests the Profusa Lumee® Oxygen Platform May Improve Clinical Management of Patients with Critical Limb Ischemia
New Insights Come as Profusa Receives CE Mark for Its Latest Generation Device, the Wireless Lumee® Oxygen Platform LEIPZIG, Germany, and EMERYVILLE, Calif., [January 30, 2020] – Profusa, a digital health company that is pioneering the next generation of personalized medicine, today announced research findings that suggest the company’s Lumee® Oxygen Platform may help improve […]
Profusa Receives CE Mark Approval to Market the Wireless Lumee® Oxygen Platform for Continuous, Real-Time Monitoring of Tissue Oxygen
Next-Generation Wireless Device May Enable Telehealth And Remote Patient Monitoring in the Future EMERYVILLE, Calif., [January 28, 2020] – Profusa, a digital health company that is pioneering the next generation of personalized medicine, today announced it has received Conformité Européenne (CE) Mark approval to market its Wireless Lumee® Oxygen Platform for continuous, real-time monitoring of […]
Profusa Recognized by Frost & Sullivan For Innovation in the Biochemical Sensors Market
Awarded 2018 Entrepreneurial Company of the Year for real-time body chemistry monitoring South San Francisco, Calif. – October 15, 2018 – Profusa, a company dedicated to the development of tissue-integrating biosensors for the continuous monitoring of body chemistries, today announced it has been awarded Entrepreneurial Company of the Year in the Continuous Monitoring Biochemical Sensors […]
Profusa to Present at DARPA D60 Symposium
Profusa Software and Systems Lead, Kevin Zhao, has been selected to participate in the Defense Advanced Research Projects Agency’s (DARPA) 60th Anniversary Symposium (D60) as a DARPA Riser. The D60 Symposium takes place from September 5-7 at the Gaylord National Resort and Convention Center, National Harbor, Maryland. DARPA hand-selected 50 early-career scientists and engineers identified […]
Profusa Closes $45 Million Series C Financing
Leading global investors join this round; financing will accelerate commercialization of Lumee™ Oxygen Platform and pioneering glucose biosensors South San Francisco, Calif. – August 14, 2018 – Profusa, a company dedicated to the development of tissue-integrating biosensors for continuous monitoring of body chemistries, today announced it has raised more than $45 million in a Series […]
Potential Utility of Tissue Oxygen Sensors in Perfusion Monitoring
Novel microsensing technology that reflects microvascular perfusion and oxygen supply in tissue shows promise in patients with chronic limb-threatening ischemia.
Injectable Body Sensors Take Personal Chemistry to a Cell Phone Closer to Reality
NEW ORLEANS, March 19, 2018 — Up until now, local inflammation and scar tissue from the so-called “foreign body response” has prevented …
Health Risk-Management: The value of real-time monitoring of body chemistries
We are becoming more accustomed to continually tracking health metrics with smart wearable devices. The next step will be implantable devices, which provide real-time monitoring of body chemistry. That future is already here and will have significant effects on how individuals and populations monitor their health. Managing risk seeks to assess and control potential adverse […]
Former Senate Majority Leader William Frist, M.D., Joins Profusa’s Board
Leading Healthcare Authority and Public Health Advocate to Advise Developer of Tissue-integrated Sensors for Real-time Monitoring of Body Chemistry SOUTH SAN FRANCISCO, Calif., June 7, 2017 — Profusa, Inc. announced today that William Frist, M.D., former U.S. Senate Majority Leader and globally acclaimed healthcare advocate, joined the company’s board of directors. Dr. Frist, partner and […]